Abnormal Glucose Tolerance and Increased Risk for Cardiovascular Disease in Japanese-Americans With Normal Fasting Glucose

Abnormal Glucose Tolerance and Increased Risk for Cardiovascular Disease in Japanese-Americans With Normal Fasting Glucose David Liao , MD , Jane B. Shofer , MS , Edward J. Boyko , MD , Marguerite J. McNeely , MD , Donna L. Leonetti , PHD , Steven E. Kahn , MB, CHB and Wilfred Y. Fujimoto , MD From...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Diabetes care 2001-01, Vol.24 (1), p.39-44
Hauptverfasser: LIAO, David, SHOFER, Jane B, BOYKO, Edward J, MCNEELY, Marguerite J, LEONETTI, Donna L, KAHN, Steven E, FUJIMOTO, Wilfred Y
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 44
container_issue 1
container_start_page 39
container_title Diabetes care
container_volume 24
creator LIAO, David
SHOFER, Jane B
BOYKO, Edward J
MCNEELY, Marguerite J
LEONETTI, Donna L
KAHN, Steven E
FUJIMOTO, Wilfred Y
description Abnormal Glucose Tolerance and Increased Risk for Cardiovascular Disease in Japanese-Americans With Normal Fasting Glucose David Liao , MD , Jane B. Shofer , MS , Edward J. Boyko , MD , Marguerite J. McNeely , MD , Donna L. Leonetti , PHD , Steven E. Kahn , MB, CHB and Wilfred Y. Fujimoto , MD From the Departments of Medicine (D.L., J.B.S., E.J.B., M.J.M., S.E.K., W.Y.F.) and Anthropology (D.L.L.), University of Washington; the Veteran's Affairs Epidemiologic Research and Information Center (E.J.B.); and the Veterans Affairs Puget Sound Health Care System (E.J.B., S.E.K.), Seattle, Washington. Address correspondence and reprint requests to David Liao, MD, Department of Medicine, Division of Metabolism, Endocrinology, and Nutrition, Health Sciences Building, Room 545, 1959 NE Pacific, University of Washington, Seattle, WA 98195. E-mail: davliao{at}u.washington.edu . Abstract OBJECTIVE — To compare the American Diabetes Association (ADA) fasting glucose and the World Health Organization (WHO) oral glucose tolerance test (OGTT) criteria for diagnosing diabetes and detecting people at increased risk for cardiovascular disease (CVD). RESEARCH DESIGN AND METHODS — Study subjects were 596 Japanese-Americans. Fasting insulin, lipids, and C-peptide levels; systolic and diastolic blood pressures (BPs); BMI (kg/m 2 ); and total and intra-abdominal body fat distribution by computed tomography (CT) were measured. Study subjects were categorized by ADA criteria as having normal fasting glucose (NFG), impaired fasting glucose (IFG), and diabetic fasting glucose and by WHO criteria for a 75-g OGTT as having normal glucose tolerance (NGT), impaired glucose tolerance (IGT), and diabetic glucose tolerance (DGT). RESULTS — Of 503 patients with NFG, 176 had IGT and 20 had DGT. These patients had worse CVD risk factors than those with NGT. The mean values for NGT, IGT, and DGT, respectively, and analysis of covariance P values, adjusted for age and sex, are as follows: intra-abdominal fat area by CT 69.7, 95.0, and 101.1 cm 2 ( P < 0.0001); total CT fat area 437.7, 523.3, and 489.8 cm 2 ( P < 0.0001); fasting triglycerides 1.40, 1.77, and 1.74 mmol/l ( P = 0.002); fasting HDL cholesterol 1.56, 1.50, and 1.49 mmol/l ( P = 0.02); C-peptide 0.80, 0.90, 0.95 nmol/l ( P = 0.002); systolic BP 124.9, 132.4, and 136.9 mmHg ( P = 0.0035); diastolic BP 74.8, 77.7, and 78.2 mmHg ( P = 0.01). CONCLUSIONS — NFG patients who had IGT or DGT had more intra-abdominal fat and total adiposity; hi
doi_str_mv 10.2337/diacare.24.1.39
format Article
fullrecord <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_journals_223050793</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A69493725</galeid><sourcerecordid>A69493725</sourcerecordid><originalsourceid>FETCH-LOGICAL-c499t-6cef7998cdfaeb84762a036272236aa66f6f43507a22ec277477bd088bcb4bbd3</originalsourceid><addsrcrecordid>eNpt0c1rFDEYBvBBFLtWz94kCIoHZ5uvmUyOy2prpShIxWN4J_PObupMsk1mFP3rzbIrBS05BMIveV7yFMVzRpdcCHXWObAQccnlki2FflAsmBZVWVWyeVgsKJO6rLTmJ8WTlG4opVI2zePihDGmJRfNovi9an2IIwzkYphtSEiuw4ARvEUCviOX3kaEhB354tJ30odI1hA7F35AsvMAkbxzaQ-I8-Qj7MBjwnI1YnQWfCLf3LQlnw4J55Am5zd_k54Wj3oYEj477qfF1_P31-sP5dXni8v16qq0UuuprC32SuvGdj1g20hVc6Ci5opzUQPUdV_3UlRUAedouVJSqbajTdPaVrZtJ06L14d3dzHczpgmM7pkcRjyrGFORtGqUZSzDF_-A2_CHH2ezeQsmiO0yOjtAW1gQON8H6YIdoM-f9oQPPYuH69qLbVQvMq8vIfn1eHo7H3-7OBtDClF7M0uuhHiL8Oo2VdujpUbLg0zQucbL45Tz-2I3Z0_dpzBqyPIlcHQ78t16c5JVklN9w-9Obit22x_uhyRo1qcMP2X-QfCIcQD</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>223050793</pqid></control><display><type>article</type><title>Abnormal Glucose Tolerance and Increased Risk for Cardiovascular Disease in Japanese-Americans With Normal Fasting Glucose</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>LIAO, David ; SHOFER, Jane B ; BOYKO, Edward J ; MCNEELY, Marguerite J ; LEONETTI, Donna L ; KAHN, Steven E ; FUJIMOTO, Wilfred Y</creator><creatorcontrib>LIAO, David ; SHOFER, Jane B ; BOYKO, Edward J ; MCNEELY, Marguerite J ; LEONETTI, Donna L ; KAHN, Steven E ; FUJIMOTO, Wilfred Y</creatorcontrib><description>Abnormal Glucose Tolerance and Increased Risk for Cardiovascular Disease in Japanese-Americans With Normal Fasting Glucose David Liao , MD , Jane B. Shofer , MS , Edward J. Boyko , MD , Marguerite J. McNeely , MD , Donna L. Leonetti , PHD , Steven E. Kahn , MB, CHB and Wilfred Y. Fujimoto , MD From the Departments of Medicine (D.L., J.B.S., E.J.B., M.J.M., S.E.K., W.Y.F.) and Anthropology (D.L.L.), University of Washington; the Veteran's Affairs Epidemiologic Research and Information Center (E.J.B.); and the Veterans Affairs Puget Sound Health Care System (E.J.B., S.E.K.), Seattle, Washington. Address correspondence and reprint requests to David Liao, MD, Department of Medicine, Division of Metabolism, Endocrinology, and Nutrition, Health Sciences Building, Room 545, 1959 NE Pacific, University of Washington, Seattle, WA 98195. E-mail: davliao{at}u.washington.edu . Abstract OBJECTIVE — To compare the American Diabetes Association (ADA) fasting glucose and the World Health Organization (WHO) oral glucose tolerance test (OGTT) criteria for diagnosing diabetes and detecting people at increased risk for cardiovascular disease (CVD). RESEARCH DESIGN AND METHODS — Study subjects were 596 Japanese-Americans. Fasting insulin, lipids, and C-peptide levels; systolic and diastolic blood pressures (BPs); BMI (kg/m 2 ); and total and intra-abdominal body fat distribution by computed tomography (CT) were measured. Study subjects were categorized by ADA criteria as having normal fasting glucose (NFG), impaired fasting glucose (IFG), and diabetic fasting glucose and by WHO criteria for a 75-g OGTT as having normal glucose tolerance (NGT), impaired glucose tolerance (IGT), and diabetic glucose tolerance (DGT). RESULTS — Of 503 patients with NFG, 176 had IGT and 20 had DGT. These patients had worse CVD risk factors than those with NGT. The mean values for NGT, IGT, and DGT, respectively, and analysis of covariance P values, adjusted for age and sex, are as follows: intra-abdominal fat area by CT 69.7, 95.0, and 101.1 cm 2 ( P &lt; 0.0001); total CT fat area 437.7, 523.3, and 489.8 cm 2 ( P &lt; 0.0001); fasting triglycerides 1.40, 1.77, and 1.74 mmol/l ( P = 0.002); fasting HDL cholesterol 1.56, 1.50, and 1.49 mmol/l ( P = 0.02); C-peptide 0.80, 0.90, 0.95 nmol/l ( P = 0.002); systolic BP 124.9, 132.4, and 136.9 mmHg ( P = 0.0035); diastolic BP 74.8, 77.7, and 78.2 mmHg ( P = 0.01). CONCLUSIONS — NFG patients who had IGT or DGT had more intra-abdominal fat and total adiposity; higher insulin, C-peptide, and triglyceride levels; lower HDL cholesterol levels; and higher BPs than those with NGT. Classification by fasting glucose misses many Japanese-Americans with abnormal glucose tolerance and less favorable cardiovascular risk profiles. Footnotes Abbreviations: ADA, American Diabetes Association; ANCOVA, analysis of covariance; ANOVA, analysis of variance; CAD, coronary artery disease; CT, computed tomography; DFG, diabetic fasting glucose; DGT, diabetic glucose tolerance; IAF, intra-abdominal fat; IFG, impaired fasting glucose; IGT, impaired glucose tolerance; JACDS, Japanese-American Community Diabetes Study; NFG, normal fasting glucose; NGT, normal glucose tolerance; OGTT, oral glucose tolerance test; WHO, World Health Organization. A table elsewhere in this issue shows conventional and Système International (SI) units and conversion factors for many substances. Accepted September 12, 2000. Received April 25, 2000. by the American Diabetes Association, Inc.</description><identifier>ISSN: 0149-5992</identifier><identifier>EISSN: 1935-5548</identifier><identifier>DOI: 10.2337/diacare.24.1.39</identifier><identifier>PMID: 11194238</identifier><identifier>CODEN: DICAD2</identifier><language>eng</language><publisher>Alexandria, VA: American Diabetes Association</publisher><subject>Abdomen ; Adult ; Aged ; Analysis of covariance ; Asian Americans ; Associated diseases and complications ; Biological and medical sciences ; Blood Glucose - analysis ; Blood Pressure ; Body Mass Index ; C-Peptide - blood ; Cardiovascular disease ; Cardiovascular Diseases - etiology ; Cholesterol ; Committees ; Coronary Disease - etiology ; Diabetes ; Diabetes Complications ; Diabetes Mellitus - blood ; Diabetes. Impaired glucose tolerance ; Endocrine pancreas. Apud cells (diseases) ; Endocrinopathies ; Etiopathogenesis. Screening. Investigations. Target tissue resistance ; Evaluation ; Fasting ; Female ; Glucose ; Glucose Intolerance ; Glucose Tolerance Test ; Glucose tolerance tests ; Glycated Hemoglobin A - analysis ; Health aspects ; High density lipoprotein ; Humans ; Insulin - blood ; Insulin resistance ; Japan - ethnology ; Japanese Americans ; Lipids - blood ; Male ; Medical sciences ; Medical tests ; Middle Aged ; Peptides ; Plasma ; Research design ; Risk Factors ; Sensitivity and Specificity ; Tomography ; Triglycerides ; Variance analysis</subject><ispartof>Diabetes care, 2001-01, Vol.24 (1), p.39-44</ispartof><rights>2002 INIST-CNRS</rights><rights>COPYRIGHT 2001 American Diabetes Association</rights><rights>Copyright American Diabetes Association Jan 2001</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c499t-6cef7998cdfaeb84762a036272236aa66f6f43507a22ec277477bd088bcb4bbd3</citedby><cites>FETCH-LOGICAL-c499t-6cef7998cdfaeb84762a036272236aa66f6f43507a22ec277477bd088bcb4bbd3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,4024,27923,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=14154909$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11194238$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>LIAO, David</creatorcontrib><creatorcontrib>SHOFER, Jane B</creatorcontrib><creatorcontrib>BOYKO, Edward J</creatorcontrib><creatorcontrib>MCNEELY, Marguerite J</creatorcontrib><creatorcontrib>LEONETTI, Donna L</creatorcontrib><creatorcontrib>KAHN, Steven E</creatorcontrib><creatorcontrib>FUJIMOTO, Wilfred Y</creatorcontrib><title>Abnormal Glucose Tolerance and Increased Risk for Cardiovascular Disease in Japanese-Americans With Normal Fasting Glucose</title><title>Diabetes care</title><addtitle>Diabetes Care</addtitle><description>Abnormal Glucose Tolerance and Increased Risk for Cardiovascular Disease in Japanese-Americans With Normal Fasting Glucose David Liao , MD , Jane B. Shofer , MS , Edward J. Boyko , MD , Marguerite J. McNeely , MD , Donna L. Leonetti , PHD , Steven E. Kahn , MB, CHB and Wilfred Y. Fujimoto , MD From the Departments of Medicine (D.L., J.B.S., E.J.B., M.J.M., S.E.K., W.Y.F.) and Anthropology (D.L.L.), University of Washington; the Veteran's Affairs Epidemiologic Research and Information Center (E.J.B.); and the Veterans Affairs Puget Sound Health Care System (E.J.B., S.E.K.), Seattle, Washington. Address correspondence and reprint requests to David Liao, MD, Department of Medicine, Division of Metabolism, Endocrinology, and Nutrition, Health Sciences Building, Room 545, 1959 NE Pacific, University of Washington, Seattle, WA 98195. E-mail: davliao{at}u.washington.edu . Abstract OBJECTIVE — To compare the American Diabetes Association (ADA) fasting glucose and the World Health Organization (WHO) oral glucose tolerance test (OGTT) criteria for diagnosing diabetes and detecting people at increased risk for cardiovascular disease (CVD). RESEARCH DESIGN AND METHODS — Study subjects were 596 Japanese-Americans. Fasting insulin, lipids, and C-peptide levels; systolic and diastolic blood pressures (BPs); BMI (kg/m 2 ); and total and intra-abdominal body fat distribution by computed tomography (CT) were measured. Study subjects were categorized by ADA criteria as having normal fasting glucose (NFG), impaired fasting glucose (IFG), and diabetic fasting glucose and by WHO criteria for a 75-g OGTT as having normal glucose tolerance (NGT), impaired glucose tolerance (IGT), and diabetic glucose tolerance (DGT). RESULTS — Of 503 patients with NFG, 176 had IGT and 20 had DGT. These patients had worse CVD risk factors than those with NGT. The mean values for NGT, IGT, and DGT, respectively, and analysis of covariance P values, adjusted for age and sex, are as follows: intra-abdominal fat area by CT 69.7, 95.0, and 101.1 cm 2 ( P &lt; 0.0001); total CT fat area 437.7, 523.3, and 489.8 cm 2 ( P &lt; 0.0001); fasting triglycerides 1.40, 1.77, and 1.74 mmol/l ( P = 0.002); fasting HDL cholesterol 1.56, 1.50, and 1.49 mmol/l ( P = 0.02); C-peptide 0.80, 0.90, 0.95 nmol/l ( P = 0.002); systolic BP 124.9, 132.4, and 136.9 mmHg ( P = 0.0035); diastolic BP 74.8, 77.7, and 78.2 mmHg ( P = 0.01). CONCLUSIONS — NFG patients who had IGT or DGT had more intra-abdominal fat and total adiposity; higher insulin, C-peptide, and triglyceride levels; lower HDL cholesterol levels; and higher BPs than those with NGT. Classification by fasting glucose misses many Japanese-Americans with abnormal glucose tolerance and less favorable cardiovascular risk profiles. Footnotes Abbreviations: ADA, American Diabetes Association; ANCOVA, analysis of covariance; ANOVA, analysis of variance; CAD, coronary artery disease; CT, computed tomography; DFG, diabetic fasting glucose; DGT, diabetic glucose tolerance; IAF, intra-abdominal fat; IFG, impaired fasting glucose; IGT, impaired glucose tolerance; JACDS, Japanese-American Community Diabetes Study; NFG, normal fasting glucose; NGT, normal glucose tolerance; OGTT, oral glucose tolerance test; WHO, World Health Organization. A table elsewhere in this issue shows conventional and Système International (SI) units and conversion factors for many substances. Accepted September 12, 2000. Received April 25, 2000. by the American Diabetes Association, Inc.</description><subject>Abdomen</subject><subject>Adult</subject><subject>Aged</subject><subject>Analysis of covariance</subject><subject>Asian Americans</subject><subject>Associated diseases and complications</subject><subject>Biological and medical sciences</subject><subject>Blood Glucose - analysis</subject><subject>Blood Pressure</subject><subject>Body Mass Index</subject><subject>C-Peptide - blood</subject><subject>Cardiovascular disease</subject><subject>Cardiovascular Diseases - etiology</subject><subject>Cholesterol</subject><subject>Committees</subject><subject>Coronary Disease - etiology</subject><subject>Diabetes</subject><subject>Diabetes Complications</subject><subject>Diabetes Mellitus - blood</subject><subject>Diabetes. Impaired glucose tolerance</subject><subject>Endocrine pancreas. Apud cells (diseases)</subject><subject>Endocrinopathies</subject><subject>Etiopathogenesis. Screening. Investigations. Target tissue resistance</subject><subject>Evaluation</subject><subject>Fasting</subject><subject>Female</subject><subject>Glucose</subject><subject>Glucose Intolerance</subject><subject>Glucose Tolerance Test</subject><subject>Glucose tolerance tests</subject><subject>Glycated Hemoglobin A - analysis</subject><subject>Health aspects</subject><subject>High density lipoprotein</subject><subject>Humans</subject><subject>Insulin - blood</subject><subject>Insulin resistance</subject><subject>Japan - ethnology</subject><subject>Japanese Americans</subject><subject>Lipids - blood</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Medical tests</subject><subject>Middle Aged</subject><subject>Peptides</subject><subject>Plasma</subject><subject>Research design</subject><subject>Risk Factors</subject><subject>Sensitivity and Specificity</subject><subject>Tomography</subject><subject>Triglycerides</subject><subject>Variance analysis</subject><issn>0149-5992</issn><issn>1935-5548</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2001</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNpt0c1rFDEYBvBBFLtWz94kCIoHZ5uvmUyOy2prpShIxWN4J_PObupMsk1mFP3rzbIrBS05BMIveV7yFMVzRpdcCHXWObAQccnlki2FflAsmBZVWVWyeVgsKJO6rLTmJ8WTlG4opVI2zePihDGmJRfNovi9an2IIwzkYphtSEiuw4ARvEUCviOX3kaEhB354tJ30odI1hA7F35AsvMAkbxzaQ-I8-Qj7MBjwnI1YnQWfCLf3LQlnw4J55Am5zd_k54Wj3oYEj477qfF1_P31-sP5dXni8v16qq0UuuprC32SuvGdj1g20hVc6Ci5opzUQPUdV_3UlRUAedouVJSqbajTdPaVrZtJ06L14d3dzHczpgmM7pkcRjyrGFORtGqUZSzDF_-A2_CHH2ezeQsmiO0yOjtAW1gQON8H6YIdoM-f9oQPPYuH69qLbVQvMq8vIfn1eHo7H3-7OBtDClF7M0uuhHiL8Oo2VdujpUbLg0zQucbL45Tz-2I3Z0_dpzBqyPIlcHQ78t16c5JVklN9w-9Obit22x_uhyRo1qcMP2X-QfCIcQD</recordid><startdate>20010101</startdate><enddate>20010101</enddate><creator>LIAO, David</creator><creator>SHOFER, Jane B</creator><creator>BOYKO, Edward J</creator><creator>MCNEELY, Marguerite J</creator><creator>LEONETTI, Donna L</creator><creator>KAHN, Steven E</creator><creator>FUJIMOTO, Wilfred Y</creator><general>American Diabetes Association</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X2</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88I</scope><scope>8AF</scope><scope>8AO</scope><scope>8C1</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AN0</scope><scope>ATCPS</scope><scope>AZQEC</scope><scope>BEC</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>HCIFZ</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>M0K</scope><scope>M0R</scope><scope>M0S</scope><scope>M0T</scope><scope>M1P</scope><scope>M2O</scope><scope>M2P</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>S0X</scope><scope>7X8</scope></search><sort><creationdate>20010101</creationdate><title>Abnormal Glucose Tolerance and Increased Risk for Cardiovascular Disease in Japanese-Americans With Normal Fasting Glucose</title><author>LIAO, David ; SHOFER, Jane B ; BOYKO, Edward J ; MCNEELY, Marguerite J ; LEONETTI, Donna L ; KAHN, Steven E ; FUJIMOTO, Wilfred Y</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c499t-6cef7998cdfaeb84762a036272236aa66f6f43507a22ec277477bd088bcb4bbd3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2001</creationdate><topic>Abdomen</topic><topic>Adult</topic><topic>Aged</topic><topic>Analysis of covariance</topic><topic>Asian Americans</topic><topic>Associated diseases and complications</topic><topic>Biological and medical sciences</topic><topic>Blood Glucose - analysis</topic><topic>Blood Pressure</topic><topic>Body Mass Index</topic><topic>C-Peptide - blood</topic><topic>Cardiovascular disease</topic><topic>Cardiovascular Diseases - etiology</topic><topic>Cholesterol</topic><topic>Committees</topic><topic>Coronary Disease - etiology</topic><topic>Diabetes</topic><topic>Diabetes Complications</topic><topic>Diabetes Mellitus - blood</topic><topic>Diabetes. Impaired glucose tolerance</topic><topic>Endocrine pancreas. Apud cells (diseases)</topic><topic>Endocrinopathies</topic><topic>Etiopathogenesis. Screening. Investigations. Target tissue resistance</topic><topic>Evaluation</topic><topic>Fasting</topic><topic>Female</topic><topic>Glucose</topic><topic>Glucose Intolerance</topic><topic>Glucose Tolerance Test</topic><topic>Glucose tolerance tests</topic><topic>Glycated Hemoglobin A - analysis</topic><topic>Health aspects</topic><topic>High density lipoprotein</topic><topic>Humans</topic><topic>Insulin - blood</topic><topic>Insulin resistance</topic><topic>Japan - ethnology</topic><topic>Japanese Americans</topic><topic>Lipids - blood</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Medical tests</topic><topic>Middle Aged</topic><topic>Peptides</topic><topic>Plasma</topic><topic>Research design</topic><topic>Risk Factors</topic><topic>Sensitivity and Specificity</topic><topic>Tomography</topic><topic>Triglycerides</topic><topic>Variance analysis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>LIAO, David</creatorcontrib><creatorcontrib>SHOFER, Jane B</creatorcontrib><creatorcontrib>BOYKO, Edward J</creatorcontrib><creatorcontrib>MCNEELY, Marguerite J</creatorcontrib><creatorcontrib>LEONETTI, Donna L</creatorcontrib><creatorcontrib>KAHN, Steven E</creatorcontrib><creatorcontrib>FUJIMOTO, Wilfred Y</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Agricultural Science Collection</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>British Nursing Database</collection><collection>Agricultural &amp; Environmental Science Collection</collection><collection>ProQuest Central Essentials</collection><collection>eLibrary</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>SciTech Premium Collection</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Agricultural Science Database</collection><collection>Consumer Health Database</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Healthcare Administration Database</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Science Database</collection><collection>Research Library (Corporate)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>SIRS Editorial</collection><collection>MEDLINE - Academic</collection><jtitle>Diabetes care</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>LIAO, David</au><au>SHOFER, Jane B</au><au>BOYKO, Edward J</au><au>MCNEELY, Marguerite J</au><au>LEONETTI, Donna L</au><au>KAHN, Steven E</au><au>FUJIMOTO, Wilfred Y</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Abnormal Glucose Tolerance and Increased Risk for Cardiovascular Disease in Japanese-Americans With Normal Fasting Glucose</atitle><jtitle>Diabetes care</jtitle><addtitle>Diabetes Care</addtitle><date>2001-01-01</date><risdate>2001</risdate><volume>24</volume><issue>1</issue><spage>39</spage><epage>44</epage><pages>39-44</pages><issn>0149-5992</issn><eissn>1935-5548</eissn><coden>DICAD2</coden><abstract>Abnormal Glucose Tolerance and Increased Risk for Cardiovascular Disease in Japanese-Americans With Normal Fasting Glucose David Liao , MD , Jane B. Shofer , MS , Edward J. Boyko , MD , Marguerite J. McNeely , MD , Donna L. Leonetti , PHD , Steven E. Kahn , MB, CHB and Wilfred Y. Fujimoto , MD From the Departments of Medicine (D.L., J.B.S., E.J.B., M.J.M., S.E.K., W.Y.F.) and Anthropology (D.L.L.), University of Washington; the Veteran's Affairs Epidemiologic Research and Information Center (E.J.B.); and the Veterans Affairs Puget Sound Health Care System (E.J.B., S.E.K.), Seattle, Washington. Address correspondence and reprint requests to David Liao, MD, Department of Medicine, Division of Metabolism, Endocrinology, and Nutrition, Health Sciences Building, Room 545, 1959 NE Pacific, University of Washington, Seattle, WA 98195. E-mail: davliao{at}u.washington.edu . Abstract OBJECTIVE — To compare the American Diabetes Association (ADA) fasting glucose and the World Health Organization (WHO) oral glucose tolerance test (OGTT) criteria for diagnosing diabetes and detecting people at increased risk for cardiovascular disease (CVD). RESEARCH DESIGN AND METHODS — Study subjects were 596 Japanese-Americans. Fasting insulin, lipids, and C-peptide levels; systolic and diastolic blood pressures (BPs); BMI (kg/m 2 ); and total and intra-abdominal body fat distribution by computed tomography (CT) were measured. Study subjects were categorized by ADA criteria as having normal fasting glucose (NFG), impaired fasting glucose (IFG), and diabetic fasting glucose and by WHO criteria for a 75-g OGTT as having normal glucose tolerance (NGT), impaired glucose tolerance (IGT), and diabetic glucose tolerance (DGT). RESULTS — Of 503 patients with NFG, 176 had IGT and 20 had DGT. These patients had worse CVD risk factors than those with NGT. The mean values for NGT, IGT, and DGT, respectively, and analysis of covariance P values, adjusted for age and sex, are as follows: intra-abdominal fat area by CT 69.7, 95.0, and 101.1 cm 2 ( P &lt; 0.0001); total CT fat area 437.7, 523.3, and 489.8 cm 2 ( P &lt; 0.0001); fasting triglycerides 1.40, 1.77, and 1.74 mmol/l ( P = 0.002); fasting HDL cholesterol 1.56, 1.50, and 1.49 mmol/l ( P = 0.02); C-peptide 0.80, 0.90, 0.95 nmol/l ( P = 0.002); systolic BP 124.9, 132.4, and 136.9 mmHg ( P = 0.0035); diastolic BP 74.8, 77.7, and 78.2 mmHg ( P = 0.01). CONCLUSIONS — NFG patients who had IGT or DGT had more intra-abdominal fat and total adiposity; higher insulin, C-peptide, and triglyceride levels; lower HDL cholesterol levels; and higher BPs than those with NGT. Classification by fasting glucose misses many Japanese-Americans with abnormal glucose tolerance and less favorable cardiovascular risk profiles. Footnotes Abbreviations: ADA, American Diabetes Association; ANCOVA, analysis of covariance; ANOVA, analysis of variance; CAD, coronary artery disease; CT, computed tomography; DFG, diabetic fasting glucose; DGT, diabetic glucose tolerance; IAF, intra-abdominal fat; IFG, impaired fasting glucose; IGT, impaired glucose tolerance; JACDS, Japanese-American Community Diabetes Study; NFG, normal fasting glucose; NGT, normal glucose tolerance; OGTT, oral glucose tolerance test; WHO, World Health Organization. A table elsewhere in this issue shows conventional and Système International (SI) units and conversion factors for many substances. Accepted September 12, 2000. Received April 25, 2000. by the American Diabetes Association, Inc.</abstract><cop>Alexandria, VA</cop><pub>American Diabetes Association</pub><pmid>11194238</pmid><doi>10.2337/diacare.24.1.39</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0149-5992
ispartof Diabetes care, 2001-01, Vol.24 (1), p.39-44
issn 0149-5992
1935-5548
language eng
recordid cdi_proquest_journals_223050793
source MEDLINE; EZB-FREE-00999 freely available EZB journals
subjects Abdomen
Adult
Aged
Analysis of covariance
Asian Americans
Associated diseases and complications
Biological and medical sciences
Blood Glucose - analysis
Blood Pressure
Body Mass Index
C-Peptide - blood
Cardiovascular disease
Cardiovascular Diseases - etiology
Cholesterol
Committees
Coronary Disease - etiology
Diabetes
Diabetes Complications
Diabetes Mellitus - blood
Diabetes. Impaired glucose tolerance
Endocrine pancreas. Apud cells (diseases)
Endocrinopathies
Etiopathogenesis. Screening. Investigations. Target tissue resistance
Evaluation
Fasting
Female
Glucose
Glucose Intolerance
Glucose Tolerance Test
Glucose tolerance tests
Glycated Hemoglobin A - analysis
Health aspects
High density lipoprotein
Humans
Insulin - blood
Insulin resistance
Japan - ethnology
Japanese Americans
Lipids - blood
Male
Medical sciences
Medical tests
Middle Aged
Peptides
Plasma
Research design
Risk Factors
Sensitivity and Specificity
Tomography
Triglycerides
Variance analysis
title Abnormal Glucose Tolerance and Increased Risk for Cardiovascular Disease in Japanese-Americans With Normal Fasting Glucose
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T03%3A16%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Abnormal%20Glucose%20Tolerance%20and%20Increased%20Risk%20for%20Cardiovascular%20Disease%20in%20Japanese-Americans%20With%20Normal%20Fasting%20Glucose&rft.jtitle=Diabetes%20care&rft.au=LIAO,%20David&rft.date=2001-01-01&rft.volume=24&rft.issue=1&rft.spage=39&rft.epage=44&rft.pages=39-44&rft.issn=0149-5992&rft.eissn=1935-5548&rft.coden=DICAD2&rft_id=info:doi/10.2337/diacare.24.1.39&rft_dat=%3Cgale_proqu%3EA69493725%3C/gale_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=223050793&rft_id=info:pmid/11194238&rft_galeid=A69493725&rfr_iscdi=true